http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
LOHAS 소비성향을 고려한 단체급식 메뉴개발이 경영성과에 미치는 영향
장승준 ( Jang Seung-jun ),최웅 ( Choi Woong ),고육미 ( Gao Yu-mei ) 한국호텔리조트학회(구 한국호텔리조트카지노산학학회) 2018 호텔리조트연구 Vol.17 No.1
In this study, Demonstrated the relationship between the use of menu development factors for users who use menu meals and the relationship between menu development factors and the relationship between menu development factors and management outcomes. The analysis of data in SPSS 22.0 programs to test the hypotheses of this research. The study results can be summarized as follows: First, the development factor of the menu has a significant impact on management performance. Second, Significant effects on quality, hygiene, and environmental performance management factors of the menu development factors of the menu development factors are shown. Third, the trend of the LOHAS consumer has shown that the effects of adjustment are significant in relation to the relationship between menu development factors and management outcomes, and the analysis results of quality, hygiene, and environmental variables are significant.
소화기; 악성 림프종 환자에서 항암화학요법 후 발생하는 B형 간염의 재활성화
장승준 ( Seung Jun Jang ),정영걸 ( Young Kul Jung ),백혜림 ( Hae Lim Baek ),윤현화 ( Hyun Hwa Yoon ),신승각 ( Seung Kak Shin ),홍준식 ( Jun Shik Hong ),박진희 ( Jin Ny Park ),권오상 ( Oh Sang Kwon ),김연수 ( Yun Soo Kim ),최덕주 ( 대한내과학회 2013 대한내과학회지 Vol.85 No.6
목적: 악성 림프종 환자에서 항암 치료 후 발생하는 B형간염의 재활성화는 중요한 합병증 중 하나이다. 이러한 B형간염의 재활성화는 항암 치료의 연기 혹은 심각한 간부전을 초래함으로써 결국 악성 림프종 환자의 생존율에 악영향을 준다. B형 간염의 재활성화는 항암 치료 전 검사에서 HBsAg양성인 환자뿐만 아니라 HBsAg 음성인 환자에서도 발생할 수 있다. 실제로 HBsAg이 음성일지라도 과거 B형 간염을 앓았거나 잠재감염 상태인 환자는 anti-HBc 양성 소견을 보인다. 본 연구는 단일 의료센터에서 6년간 항암 치료를 받은196명의 환자를 후향적으로 분석하여 B형 간염의 재활성화 율과 이를 예방하기 위한 방법에 대해 알고자 한다. 방법: 2005년 1월부터 2010년 12월까지 가천대 길병원에서 악성 림프종을 진단받고 항암 치료를 시행받은 196명이 환자들의 검사 결과 및 임상경과 자료를 후향적 분석하였다. 결과: 악성 림프종을 진단받은 총 196명의 환자에 대해항암 치료 전 HBsAg 검사율은 88% (172/196)였으며 11명이 양성이었다. Anti-HBc 검사율은 13% (26/196)에 그쳤으며 HBsAg 음성이면서 Anti-HBc 양성인 환자는 15명이었다. 재활성화는 HBsAg 양성군에서 27.3% (3/11), HBsAg 음성군에서 6.7% (1/15) 발생하였으며 이들은 entecavir 혹은 lamivudine복용 후에 모두 후유증 없이 간기능을 회복하였으며 항암치료를 종료하였다. 결론: HBsAg 양성인 환자뿐만 아니라 과거감염이나 회복된 감염을 의미하는 Anti-HBc 양성인 환자에서도 재활성화는 발생하였다. 따라서 항암 치료 시작 전에 B형 간염 바이러스에 대한 상태를 평가하고 재활성화를 예방하기 위한 적절한 검사와 선제 치료가 필요하다. Background/Aims: Reactivation of hepatitis B virus (HBV) has been reported in HBV surface antigen (HBsAg)-positive patients undergoing chemotherapy, as well as HBsAg-negative patients with antibodies against HBV core antigen (HBcAg) and/or HBsAg (HBsAb). Chemotherapy-including rituximab-has recently been identified as a predictive factor for HBV reactivation in HBsAg- negative patients with malignant lymphoma. The aim of our study was to identify the factors predictive of HBV reactivation after chemotherapy in patients with malignant lymphoma. Methods: We conducted a retrospective analysis of medical records from patients diagnosed with malignant lymphoma at Gachon University Gil Medical Center in City, County from January 2005 to December 2010. We subsequently determined HBsAg, HBsAb and anti-HBc status in the 196 patients treated with chemotherapy. Results: The mean age of the patients was 57.3 ± 14.5 years; 56.3% were male. A total of 172 of 196 (88%) patients in the study population were HBsAg (+) prior to chemotherapy. Three patients (3/11, 27.3%) in the HBsAg (+) group had confirmed HBV reactivation after chemotherapy. In addition, 26 of 196 (13%) patients in the study population tested HBcAg (+) positive prior to chemotherapy. One patient (1/15, 6.7%) in the HBsAg (-)/HBcAb (+) group had confirmed HBV reactivation. In the four patients with HBV reactivation, infection was resolved after treatment with 0.5 mg entecavir or 100 mg lamivudine. Conclusions: Reactivation of HBV after systemic chemotherapy can occur in HBsAg (-) patients. We recommend that malignant lymphoma patients undergoing chemotherapy be screened for HBV infection status, including HBcAg, and followed closely to prevent HBV reactivation. (Korean J Med 2013;85:598-603)
내시경적 큰풍선확장술을 이용한 어려운 담관 결석 추출 시풍선확장시간에 대한 비교 연구
이승익 ( Seung Ik Lee ),장승준 ( Seung Jun Jang ),한송이 ( Song Yi Han ),박평화 ( Pyung Hwa Park ),이연희 ( Yeon Hee Lee ),장필규 ( Pil Kyu Jang ),김주현 ( Ju Hyeon Kim ),조재희 ( Jae Hee Cho ),김연석 ( Yeon Suk Kim ) 대한췌장담도학회 2014 대한췌담도학회지 Vol.19 No.4
Background/Aims: The ballooning time in endoscopic papillary large balloon dilation (EPLBD) remains controversial. The aim of this study was to evaluate the significance of the ballooning time comparing an immediate balloon deflation method with a conventional ballooning time of > 45 seconds. Methods: Between January 2010 and December 2010, 126 patients with bile duct stones treated with EPLBD and endoscopic sphincterotomy were divided according to the ballooning time: the immediate deflation group (n=56) and the conventional inflation group (ballooning time 45s to < 60s) (n=70). Results: The overall success rate and the success rate of the first attempt of ERCP (endoscopic retrograde cholangio-pancreatography) were 96.4% (54/56) and 80.4% (45/56) in the immediate group and 97.1% (68/70) and 77.1% (54/70) in the conventional inflation group. There were no statistically significant differences in the overall success and the first attempt of ERCP success rate (p=0.99, p=0.66). The frequency of mechanical lithotripsy was 0% in the immediate deflation group and 7.1% in the conventional inflation group (p=0.065). Complications occurred in 3.6% (2/56) patients in the immediate deflation group and 8.6% (4/70) patients in the conventional inflation group (p=0.298). Conclusions: The ballooning time in EPLBD does not affect the outcomes of the treatment for bile duct stones. And the feasibility of the immediate deflation method in EPLBD is acceptable. Korean J Pancreatobiliary 2014;19(4):182-188
이동민 ( Dong Min Lee ),권오상 ( Oh Sang Kwon ),최윤이 ( Youn-i Choi ),신승각 ( Seung Kak Shin ),장승준 ( Seung Jun Jang ),서현정 ( Hyunjung Seo ),이종준 ( Jong Joon Lee ),최덕주 ( Duck Joo Choi ),김연수 ( Yun Soo Kim ),김주현 ( J 대한소화기학회 2018 대한소화기학회지 Vol.72 No.2
Simple hepatic cysts are common benign liver lesions that usually have no malignant capability. They are generally asymptomatic and are often found incidentally by abdominal imaging procedures. Treatment becomes necessary, however, when huge hepatic cysts cause symptoms and develop complications, such as hemorrhage, adjacent organ damage, and infection. Several therapeutic options have been performed for symptomatic and huge cysts, including the aspiration of cystic fluid, infusion of various sclerosing agents, and surgical intervention. The optimal management of huge hepatic cysts is controversial and each option has its complications and limitations. This paper reports a case of a 66-year-old woman diagnosed with a simple hepatic cyst 2 years earlier, who was referred to hospital due to abdominal pain. The diagnosis was a huge hepatic cyst with symptoms by abdominal imaging studies. During the follow-up period, the huge cysts resolved spontaneously without treatment. (Korean J Gastroenterol 2018;72:86-89)